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ABSTRACT
Objective: To determine through preoperative serum PSA level, Gleason score on biopsy
and percentage of fragments affected by tumor on biopsy, the probability of involvement of the semi-
nal vesicles.
Materials and Methods: During the period between March 1991 to December 2002, we
selected 899 patients undergoing radical prostatectomy for treatment of localized prostate adenocar-
cinoma. The analyzed preoperative variables were PSA, percentage of positive fragments and Gleason
score on the biopsy. Pre-operative PSA was divided in scales from 0 to 4.0 ng/mL, 4.1 to 10 ng/mL,
10.1 to 20 ng/mL and > 20 ng/mL, Gleason score was categorized in scales from 2 to 6. 7 and 8 to 10,
and the percentage of affected fragments was divided in 0 to 25%, 25.1% to 50%, 50.1% to 75%, and
75.1% to 100%. All these variables were correlated with the involvement of seminal vesicles in the
surgical specimen.
Results: Of the 899 patients under study, approximately 11% (95% CI, [9% - 13%]) had
involvement of seminal vesicles. On the multivariate analysis, when PSA was ≤ 4, the Gleason score
was 2 to 6, and less than 25% of fragments were involved on the biopsy, only 3.6%, 7.6% and 6.2% of
patients respectively, had involvement of seminal vesicles. On the multivariate analysis, we observed
that PSA, Gleason score and the percentage of involved fragments were independent prognostic fac-
tors for invasion of seminal vesicles.
Conclusion: The preoperative variables used in the present study allow the identification of
men with minimal risk (lower than 5%) if involvement of seminal vesicles.
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INTRODUCTION
Radical prostatectomy (RP) is the most ef-
fective approach for treating localized prostate can-
cer (PCa) (1). However, almost 30% of patients will
present biochemical recurrence of the disease on the
long term (2). The involvement of seminal vesicles
constitutes one of the main prognostic factors follow-
ing RP (2-4), since these patients present higher inci-
dence of lymph nodal metastases and rates of bio-
chemical recurrence in up to 60% of cases within 5
years (3,4). Moreover, (6 to 26%) of patients under-
going RP have involvement of the seminal vesicles
(4,5), and for all these reasons, since its original de-
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scription in 1905 by Young (6), the classic technique
of retropubic RP involves the en-bloc removal of all
prostate and seminal vesicles.
With the advent of the prostate specific anti-
gen (PSA), the majority of patients are diagnosed in
early stages of disease, and currently more than 60%
are classified as T1c (7). Thus, less frequently pa-
tients undergoing RP present involvement of seminal
vesicles, and their resection may be unnecessary in
more than 90% of cases (5).
Since the removal of the seminal vesicles can
be technically difficult in some cases, increasing the
surgical time and blood loss, and their removal can
exert some influence on the erectile function and re-
covery of urinary continence, in many patients (3,8,9),
the preoperative identification of cases with low risk
of involvement of seminal vesicles might select cases
for surgery with preservation of seminal vesicles,
improving the quality of life of these patients follow-
ing the surgery.
Since digital rectal examination of the pros-
tate, imaging studies, and biopsy of the seminal
vesicles fail to detect the involvement of seminal
vesicles in patients with localized PCa (3), the pre-
operative prognostic factors more commonly used for
predicting tumor extension are PSA, Gleason score
and clinical staging (7). Recently, some authors pro-
posed that in patients with PSA lower than to 10.0
ng/mL, when the Gleason score was lower than 7 or
less than 50% of fragments were involved, there
would be a risk of involvement of seminal vesicles
lower than 5%, and they could be preserved during
RP (5).
In the present study, the objective was to as-
sess the probability of involvement of seminal vesicles
using preoperative PSA, Gleason score and the per-
centage of positive fragments on prostate biopsy.
MATERIALS AND METHODS
During the period from March 1991 to De-
cember 2002, we selected 960 patients undergoing
RP for management of localized PCa at Syrian Leba-
nese Hospital, São Paulo, Brazil. The same surgeon
performed all procedures and the same pathologist
performed the pathologic analyses of the specimen.
Data from the 960 selected patients, as well
as the number of fragments removed on biopsy, the
number of fragments with cancer, Gleason score, PSA
and the pathological study of the surgical specimen
were retrieved from our database.
We excluded 54 patients who received
neoadjuvant treatment and 7 who were diagnosed
through endoscopic resection of the prostate or
transvesical prostatectomy, leaving a total of 899 pa-
tients. All patients underwent clinical staging, using
the TNM classification (AJCC, 1992), using diagnos-
tic testes that included dosage of serum PSA, digital
rectal examination, transrectal prostate biopsy, ab-
dominal and pelvic computerized tomography, bone
scintigraphy and chest radiography.
Preoperative variables analyzed were PSA,
the percentage of positive fragments and Gleason
score on biopsy. Preoperative PSA was categorized
in scales from 0 to 4.0 ng/mL, 4.1 to 10 ng/mL, 10.1
to 20 ng/mL and > 20 ng/mL, and the Gleason score
was divided in scales from 2 to 6. 7 and 8 to 10. The
percentage of positive fragments was defined as the
number of fragments with cancer divided by the total
number of fragments on biopsy, divided in ranges from
0 to 25%, 25.1% to 50%, 50.1% to 75%, 75.1% to
100%. All these variables were related to the involve-
ment of the seminal vesicles in the surgical speci-
men.
Mean age was 62.8 ± 7.4 years (ranging from
40 to 83 years). Mean PSA was 10.1 ± 7.7 ng/mL
(ranging from 0.3 to 72 ng/mL). In relation to the
clinical stage, 432 (48%) patients were classified as
T1c, 219 (24%) as T2a, 173 (19.3%) as T2b, 68
(7.6%) as T2c and 7 (0.8%) as T3a. The mean per-
centage of affected fragments was 41% ± 24% (rang-
ing from 5% to 100%). Mean Gleason score on bi-
opsy was 5.8 ± 1.3, ranging from 2 to 9.
RP specimens (prostate, seminal vesicles and
obturator lymph nodes) were fixed, in average dur-
ing 6 hours, in 10% formalin and underwent a rou-
tine consisting of measurement and weighting of the
gland in a digital balance sensitive to 2 decimal places.
Thin transversal sections were made on the surgical
margins relative to the bladder neck and prostate apex.
Considering the urethra for reference, the remaining
gland, after its margins had been stained with India
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ink, were sequentially sliced at each 3 millimeters.
Eight to 10 sections from each lobe were included
for the histological study. The seminal vesicles were
sectioned at the base, and were prepared for histo-
logical examination after longitudinal sectioning. The
involvement of seminal vesicles was considered only
when there was parenchymal invasion, without con-
sidering adventitial invasion.
Statistical assessment was performed through
Pearson qui-square test and trend test for univariate
analysis. For multivariate analysis, an approach of
logistic regression was used. A significance level of
5% was adopted, thus, p values < 0.05 were consid-
ered statistically significant.
RESULTS
Of the 899 patients under study, approxi-
mately 11% (95% CI, 9% - 13%) had involvement of
seminal vesicles. In relation to preoperative PSA, we
observed that 9.3% (84) of the total of assessed pa-
tients presented levels lower or equal to 4.0 ng/mL.
Table-1 shows the distribution of patients according
to the involvement of seminal vesicles and preopera-
tive PSA levels. The likelihood of presenting involve-
ment of seminal vesicles increases according to the
increase in preoperative serum PSA levels (p < 0.001).
Gleason score on biopsy showed association
with the involvement of seminal vesicles as well (p <
0.001). Observing the Table-2 we verified that there
is no statistically significant difference between the
distribution of Gleason score 7 and 8 to 10 (p = 0.994),
therefore we constructed a new category for scores
between 7 to 10. According to the Table-3, approxi-
mately 8% of patients with Gleason score between 2
and 6 had involvement of seminal vesicles. On the
other hand, among men with Gleason score between
7 and 10, 46 (19%) out of 245 had involvement of
seminal vesicles.
The qui-square test showed a significant as-
sociation between the percentage of affected frag-
ments and involvement of seminal vesicles (p <
0.001). The Table-4 shows that as the percentage of
affected fragments increase there is an increase in the
Table 1 – Distribution of PSA levels according to the involvement of seminal vesicles (ISV).
PSA (ng/mL)
0 – 4.0
4.1 – 10.0
10.1 – 20.0
> 20.0
Total
Patients
  N (%)
084 (9.3)
512 (57.0)
236 (26.3)
067 (7.4)
899 (100.0)
03 (3.6)
43 (8.4)
36 (15.2)
14 (20.9)
96 (10.7)
081 (96.4)
469 (91.6)
200 (84.8)
053 (79.1)
803 (89.3)
Without ISV
N (%)
With ISV
N (%)
Table 2 – Distribution of Gleason score according to the involvement of seminal vesicles (ISV).
Gleason Score
2 to 6
7
8 to 10
Total
 Patients
  N (%)
654 (72.8)
165 (18.3)
080 (8.9)
899 (100.0)
With ISV
 N (%)
 50 (7.6)
 31 (18.8)
 15 (18.7)
 96 (10.7)
Without ISV
     N (%)
  604 (92.4)
  134 (81.2)
  065 (81.3)
  803 (89.3)
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Table 3 – Distribution of grade according to the involvement of seminal vesicles (ISV).
Gleason Score
2 to 6
7 to 10
Total
  Patients
   N (%)
654 (72.8)
245 (27.2)
899 (100.0)
With ISV
  N (%)
 50 (7.6)
 46 (18.8)
 96 (10.7)
Without ISV
     N (%)
   604 (92.4)
   199 (81.2)
   803 (89.3)
Table 4 – Distribution of percentage of positive fragments according to the involvement of seminal vesicles (ISV).
Percentage
0 to 25%
25.1 to 50%
50.1 to 75%
75.1 to 100%
Total
  Patients
   N (%)
290 (32.3)
393 (43.7)
134 (14.9)
082 (9.1)
899 (100.0)
With ISV
  N (%)
  18 (6.2)
  37 (9.4)
  18 (13.4)
  23 (28.1)
  96 (10.7)
Without ISV
     N (%)
   272 (93.8)
   356 (90.6)
   116 (86.6)
   059 (71.9)
   803 (89.3)
proportion of patients with involvement of seminal
vesicles (p < 0.001).
PSA levels, Gleason score and the percent-
age of positive fragments contributed significantly for
predicting the involvement of seminal vesicles in lo-
gistic regression (p < 0.001). All second- and third-
order interactions were tested and shown to be non
significant (p > 0.05). Thus, the final model included
only the main effects, which were shown to be inde-
pendent prognostic factors for involvement of semi-
nal vesicles.
The figures presented in each cell of Table-5
represent the probability of involvement of seminal
vesicles based on logistic regression with PSA,
Gleason score and percentage of affected fragments.
For example, a man with PSA lower than or equal to
4.0 ng/mL, percentage of affected fragments up to
75% and Gleason score between 2 and 6 has a chance
of less than 5% of presenting involvement of seminal
vesicles. The same risk is observed for men with PSA
lower than or equal to 10 ng/mL, percentage of af-
fected fragments up to 25% and Gleason score of 6.
On the other hand, men with PSA higher than 10 ng/
mL, more than 75% of affected fragments and
Gleason score above 6 have a risk higher than 40%
of presenting involvement of seminal vesicles.
COMMENTS
In the present study, the authors demonstrated
that in earlier cases, the involvement of seminal
vesicles is uncommon, and this probability can be
determined through the studied variables. Thus, in
univariate analysis, when PSA is ≤ 4, Gleason score
is between 2 to 6 and less than 25% of biopsy frag-
ments are involved, only 3.6%, 7.6% and 6.2% of
patients respectively, will have involvement of semi-
nal vesicles.
Among advantages reported in the literature
concerning the preservation of seminal vesicles is the
improvement in urinary continence and postopera-
tive sexual potency (8,9). Additionally, some cases
present technical difficulties during the resection, in-
creasing surgical time and blood loss (3).
Rates of post-RP urinary continence de-
creased with the increasing anatomic knowledge on
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neurovascular bundles. Moreover, better technical
improvement, especially during dissection of the pros-
tate apex, has enabled better preservation of the ex-
trinsic sphincteric muscles (10). Despite these ad-
vances, urinary incontinence continues to impair the
quality of life of some patients, and can reach 60%
during the first 6 months after surgery (10).
Accurate surgical measures that influence
post-RP urinary continence are not fully understood,
and recent studies suggest that trigone innervation and
posterior urethral sensitivity play an important role
in continence during the immediate postoperative
period (8). These nerve branches can be damaged
during dissection of the prostate, posterior aspect of
bladder and seminal vesicles, contributing for sphinc-
teric incompetence (8). Thus, the preservation of semi-
nal vesicles would prevent traction and damage to
such structures, improving immediate postoperative
continence.
Jonh et al. (8) studied the urinary continence
in 20 patients undergoing RP with preservation of
seminal vesicles and compared their results to other
34 patients undergoing classic RP. They observed that
in the group with preservation of seminal vesicles,
the continence rates at 6 weeks and 6 months follow-
ing surgery were 60% and 95% respectively, versus
18% and 82% during the same periods for the group
undergoing classic surgery.
The removal of seminal vesicles during RP
is also partially implied as a cause of erectile dys-
function in many patients (3,8). Sexual function can
be affected after RP despite the use of techniques that
preserve the neurovascular bundles, showing that
other mechanisms are involved in this process. The
close relationship between the seminal vesicles and
the lateral prostate pedicles, with penile blood sup-
ply and their own neurovascular bundles, suggest that
the resection of the seminal vesicles can actually con-
tribute for postoperative erectile dysfunction (5). Stud-
ies on sexual function with patients undergoing RP
techniques with preservation of the seminal vesicles
show a clear advantage when compared with patients
undergoing classic RP. In a series of 191 patients that
were prospectively assessed, the authors observed that
sexual health in relation to the quality of life was sig-
nificantly better in patients with preservation of semi-
nal vesicles when compared with patients undergo-
ing classic surgery (9).
In addition to these factors, the low frequency
of PCa invasion to the seminal vesicles often makes
their removal unnecessary. One study assessing the
surgical specimens from 71 consecutive patients un-
dergoing RP, found 12 cases (17%) of involvement
of seminal vesicles, with 5 bilateral cases, but in none
of theses cases the tumor had spread to the distal 1
cm of seminal vesicles. The authors comment that in
cases of technical difficulty, even if a small fragment
of seminal vesicles is not removed, the patient’s prog-
nosis probably will not change (11).
Thus, it is clear that preoperative identifica-
tion of patients with involvement of seminal vesicles,
in addition to being an important factor for staging
and prognosis, can help to select cases for preserva-
tion of the seminal vesicles. In patients with local-
ized PCa, imaging studies have limited accuracy and
the biopsies of seminal vesicles have negative, posi-
Table 5  – Prediction of involvement of seminal vesicles according to PSA, grade and percentage of fragments involved by
the tumor.
            Grade 8 to 10
PSA       PSA PSA     PSA
0 to 4  4.1 to 10  10.1 to 20   ≥ 20
   5 10  17          ...
   6 13  22 27
   X 16  25 31
   x          30  44 51
Percentage
0 to 25%
25.1 to 50.0%
50.1 to 75%
75.1 to 100%
               Grade 2 to 6
PSA        PSA        PSA     PSA
0 to 4   4.1 to 10   10.1 to 20   ≥ 20
  2            4                7      10
  3            6              10      13
  3            7              12      16
  7          15              24      30
                   Grade 7
PSA   PSA     PSA    PSA
0 to 4   4.1 to 10 10.1 to 20  ≥ 20
   5    10       17     22
7    14       23     28
8    16       26     32
 17    31       45     53
Note: The figures represent the predicted probability as a percentage. x = insufficient data for estimating probability.
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tive predictive value and sensitivity of only 84 to 97%,
80% and 67% respectively (3). Thus it is necessary
to identify risk factors for involvement of seminal
vesicles, with main preoperative prognostic factors
and serum PSA levels, Gleason score on biopsy and
clinical staging (7).
The percentage of positive fragments on bi-
opsy is associated with pathological characteristics,
biochemical progression, distant metastases and over-
all survival in patients undergoing RP. Recent works
show that this parameter must be used in preopera-
tive models for predicting the prognosis (12). Peller
et al. (13), while studying the usefulness of transrectal
prostate biopsy for determining tumor extension of
PCa in 102 patients undergoing RP, observed that the
number of positive fragments was correlated with the
involvement of seminal vesicles. Thus, when up to
50% or fragments were affected, only 10% presented
involvement, versus 57% when more than 50% of
fragments were affected (13). The present study dem-
onstrated that similarly, when no more than 50% of
fragments are affected, the risk of involvement of
seminal vesicles is 10%, however when more than
50% of fragments are affected, such risk is superior
to 28%.
The presence of positive fragments removed
from the prostate base is also correlated with involve-
ment of seminal vesicles. In a study with 763 patients
with clinical stage T1c to T3 undergoing RP, 437 pa-
tients presented positive fragments at the base and
12.8% of those had involvement of seminal vesicles,
versus only 1.2% of 326 patients without PCa at the
base. On the multivariate analysis, serum PSA, pri-
mary Gleason grade, and the percentage of PCa at
the base were the only prognostic factors implied in
the involvement of seminal vesicles (3).
Zlotta et al. (5), in a retrospective study with
1238 patients, observed that when PSA was < 10.0
ng/mL, only 5.2% had involvement of seminal
vesicles. On the multivariate analysis, the percentage
of affected fragments on biopsy and Gleason score
were predictive factors for involvement of seminal
vesicles in this group of patients. Thus, in patients
with PSA < 10.0 ng/mL, when the Gleason score was
< 7 or less than 50% of the fragments were involved,
there was a risk lower than 5% of involvement of
seminal vesicles. In the present series, when the PSA
was ≤ 10 ng/mL, we observed an 8.4% risk of in-
volvement of seminal vesicles on univariate analy-
sis. On the multivariate analysis we observed only 2
situations where the risk of involvement of seminal
vesicles was lower than 5%, that is, PSA up to 4 ng/
mL with a maximum of 75% of fragments affected
by tumor and Gleason score lower than or equal to
6, and PSA under 10 ng/mL with up to 25% of frag-
ments affected and Gleason score of 6 at a maxi-
mum. In no case with more than 75% of affected
fragments or Gleason score higher than 6, there was
a risk lower than 5% for involvement of seminal
vesicles.
Since we still do not know the long-term ef-
fects of preserving the seminal vesicles, in the future
this study could help to create study protocols that
enable their preservation. The authors still recommend
en-bloc removal of the seminal vesicles during RP
however, in selected cases presenting the parameters
mentioned above, non-removal of the entire seminal
vesicles probably will not impair patients’ prognosis
due to the low risk for their involvement.
Adriana Sañudo performed the statistical analysis
REFERENCES
1. Cooperberg MR, Broering JM, Latini DM, Litwin MS,
Wallace KL, Carroll PR: Patterns of practice in the
United States: insights from PCaSURE on prostate
cancer management. Curr Urol Rep. 2004; 5: 166-72.
2. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan
MW, Scardino PT: Cancer control with radical pros-
tatectomy alone in 1,000 consecutive patients. J Urol.
2002; 7: 528-34.
3. Koh H, Kattan MW, Scardino PT, Suyama K, Maru N,
Slawin K, et al.: A nomogram to predict seminal vesicle
invasion by the extent and location of cancer in system-
atic biopsy results. J Urol. 2003; 170: 1203-8.
4. Sofer M, Savoie M, Kim SS, Civantos F, Soloway MS:
Biochemical and pathological predictors of the recur-
rence of prostatic adenocarcinoma with seminal vesicle
invasion. J Urol. 2003; 169: 153-6.
5. Zlotta AR, Roumeguere T, Ravery V, Hoffmann P,
Montorsi F, Turkeri L, et al.: Is seminal vesicle abla-
478
SEMINAL VESICLES INVOLVEMENT IN PROSTATE CA
tion mandatory for all patients undergoing radical pros-
tatectomy? A multivariate analysis on 1283 patients.
Eur Urol. 2004; 46: 42-9.
6. Young HH: The early diagnosis and radical cure of
carcinoma of the prostate. Being a study of 40 cases
and presentation of a radical operation which was car-
ried out in four cases. 1905. J Urol. 2002; 167: 939-
46; discussion 947.
7. Partin AW, Mangold LA, Lamm DM, Walsh PC,
Epstein JI, Pearson JD: Contemporary update of pros-
tate cancer staging nomograms (Partin Tables) for the
new millennium. Urology. 2001; 58: 843-8.
8. John H, Hauri D: Seminal vesicle-sparing radical pros-
tatectomy: a novel concept to restore early urinary
continence. Urology. 2000; 55: 820-4.
9. Sanda MG, Dunn R, Wei J: Seminal vesicle sparing
technique is associated with improved sexual HRQOL
outcome after radical prostatectomy. J Urol. 2002; 167:
151, A606.
10. Steiner MS, Morton RA, Walsh PC: Impact of ana-
tomical radical prostatectomy on urinary continence.
J Urol. 1991; 145: 512-4; discussion 514-5.
11. Korman HJ, Watson RB, Civantos F, Block NL,
Soloway MS: Radical prostatectomy: is complete re-
section of the seminal vesicles really necessary? J Urol.
1996; 156: 1081-3.
12. Lotan Y, Shariat SF, Khoddami SM, Saboorian H,
Koeneman KS, Cadeddu JA, et al.: The percent of bi-
opsy cores positive for cancer is a predictor of ad-
vanced pathological stage and poor clinical outcomes
in patients treated with radical prostatectomy. J Urol.
2004; 171: 2209-14.
13. Peller PA, Young DC, Marmaduke DP, Marsh WL,
Badalament RA: Sextant prostate biopsies. A histo-
pathologic correlation with radical prostatectomy
specimens. Cancer. 1995; 75: 530-8.
Received: September 13, 2004
Accepted after revision: October 27, 2004
Correspondence address:
Dr. Marcos F. Dall’Oglio
Rua Barata Ribeiro, 398 / 5o.
São Paulo, SP, 01308-000, Brazil
Fax: + 55 11 3159-3618
E-mail: marcosdallogliouro@terra.com.br
